defactinib,pembrolizumab
merck,verastem
['pembro', 'defactinib', 'pancreatic']
#cedarssinaicancer at #asco22. a randomized phase ii study of pembrolizumab +/- defactinib following chemotherapy as a neoadjuvant &amp; adjuvant treatment for resectable pancreatic ductal #adenocarcinoma is being presented. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.